| Tag | Content |
|---|
EnhancerAtlas ID | HS176-02560 |
Organism | Homo sapiens |
Tissue/cell | SK-N-SH |
Coordinate | chr1:161699710-161700550 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| Nr2f6(var.2) | MA0728.1 | chr1:161699848-161699863 | TGAACTCCTGACCTC | - | 6.22 | | TBX21 | MA0690.1 | chr1:161700095-161700105 | TTCACACCTT | - | 6.02 | | TBX2 | MA0688.1 | chr1:161700094-161700105 | ATTCACACCTT | - | 6.02 |
|
| | Number of super-enhancer constituents: 4 | ID | Coordinate | Tissue/cell |
| SE_56629 | chr1:161698532-161702049 | u87 | | SE_58760 | chr1:161674084-161711741 | Ly1 | | SE_59497 | chr1:161674276-161714796 | Ly3 | | SE_61570 | chr1:161674449-161712145 | Toledo |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH01I161729 | chr1 | 161699268 | 161701012 |
|
Enhancer Sequence | ACCTCCGCCT CCCAGGTTCA AGTGATTCTT CCACCTCAGC CTCCCCAGTA GCTGGGATTA 60
CAGGCACCTG CCATCATGCC AGGCTAATTT TTGTATTTTT GTAGAGACGG GGTTTCACCG 120
TGTTGGCCAG GCTGGTCTTG AACTCCTGAC CTCAGGTGAT CCACCTGCCT CAGCCTCCCA 180
AAGTGCAGGG ATTACAGGCT TGGGCCACCG CGCCCGGCCG GTTTCTGCCA TCTTGATATA 240
GACAGGAAGT GACTAACATT AGTGGCAAGA GGCTTAGTAA TCAAAGAATC TCAGGTCATT 300
TAAAAAATCA GTTGATCATT TTTTAAGAGT ACAAAAAAGA GAAATAGTTA CTCAAAGGAG 360
AGCTAGGGCA GCAGTATCTC TTTCATTCAC ACCTTTTTGG CAACATCAAC ATCCTTGTTC 420
TTGTTTTGCC ATCTACTTCC ATTTAGAACT AGGATGCGGG GGGATGGGGA AGAACAAGGA 480
CTTTTTGGTG AGAGTGAAAA TCATTCATGA CTCAACTTTC TGGTGTAGGG GAGAGGAATT 540
GACTCATATG GCCTGTAGAC TCCACTGTCT TCTTCGTGTA CCCCAGCTTT TAAGAGGAGG 600
GCAGGATCAA GATGATCTTC TAAGATATCT GTTATTGATC TCCCAGGAAG ACCTGCATTA 660
AGGAAATATC AGCTTCATCT TCATCCCTTT TGTTTGAGGT TCCTACATGC ATTTAGGGAA 720
ACCAGAAGGC TAGCTAGCCC AGGTTGTCCA AGGGGACTCT CAGAGCTCAT TCCCAAACAG 780
CAGGGATGGC AGAAAAATGC TGGAGAAACC TAGGGAGGAA TCTGCTTCTC TCTGATACTC 840
|
